logo

For the Inventor, By the Inventor

Fishers, NJ, United States of America

Janice M Hitchcock

This inventor holds 4 USPTO granted patents. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2001-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janice M Hitchcock. Retrieved from https://idiyas.com/inventor/janice-m-hitchcock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 75.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Neshanic Station, NJ (US) (2001)
  • Fishers, IN (US) (2003 - 2005)
  • Fishers, NJ (US) (2006)

Company Filing History:

goldMedal4 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents

Years Active: 2001-2006

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7132433 - Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease (2006-11-07),
2. 6939879 - Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia (2005-09-06),
3. 6613779 - Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disorders (2003-09-02),
4. 6277864 - Use of R- +)-&agr;-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders (2001-08-21),

Title: Janice M Hitchcock: Innovator in Pharmaceutical Treatments

Introduction

Janice M Hitchcock is a notable inventor based in Fishers, NJ (US), recognized for her contributions to the field of pharmaceuticals. With a total of 4 patents, she has made significant strides in developing treatments for various psychological and behavioral symptoms associated with neurological diseases.

Latest Patents

Among her latest patents, one focuses on the use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in treating behavioral or psychological symptoms associated with Alzheimer's disease, Lewy body dementia, or Parkinson's disease. This invention aims to provide effective treatment options for patients suffering from these debilitating conditions. Another patent addresses the use of R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance-induced insomnia, offering symptomatic relief to patients in need.

Career Highlights

Janice M Hitchcock is currently employed at Aventis Pharmaceuticals Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work has been instrumental in advancing treatment methodologies that address critical health issues.

Collaborations

Throughout her career, Janice has collaborated with esteemed colleagues such as Stephen M Sorensen and Cesare Mondadori, further enhancing her research and development efforts.

Conclusion

Janice M Hitchcock's innovative work in pharmaceuticals highlights her commitment to improving patient care through effective treatments. Her contributions are invaluable in the ongoing fight against neurological diseases and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…